Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The protein p21 (WAF1, CIP1 or sdi1), induced by the tumour-suppressor protein p53, interacts with and inhibits two different targets essential for cell-cycle progression. One of these is the cyclin-Cdk family of kinases and the other is the essential DNA replication factor, proliferating-cell nuclear antigen (PCNA). We report here that separate domains of p21 are responsible for interacting with and inhibiting the two targets. An amino-terminal domain inhibits cyclin-Cdk kinases and a carboxy-terminal domain inhibits PCNA. Using these separated domains, we have determined that p21 inhibits different biological systems through different targets. The PCNA-binding domain is sufficient for inhibition of DNA replication based on simian virus 40, whereas the Cdk2-binding domain is sufficient for inhibition of DNA replication based on Xenopus egg extract and for growth suppression in transformed human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [49]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
Research works printed but not linked: 1
- el-Deiry, W. et al. Cancer Res. 54, 1169–1174 (1994).
Cited by
Items 401–500 of 548
Thullberg, M., Welcker, M., Bártková, J., Kjerulff, A. A., Lukas, J., Johan, H. V. E., & Bartek, J. (2000) · Hybridoma · doi:10.1089/027245700315806 · Cited by 17
“…of our findings of these distinct complexes recognizable by different antibodies is that the cdks interact with p21 in unique modes, possibly through at least partly nonoverlapping sequences within the N-terminal domain of p21, (10,11) and in the vicinity of the epitopes recognized by the MAbs.”
Interaction of human thymidine kinase 1 with p21Waf1
Huang, D.-Y., & Chang, Z.-F. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560829 · Cited by 17
Use of Peptides from p21 (Waf1/Cip1) to Investigate PCNA Function in Xenopus Egg Extracts
Mattock, H., Jares, P., Zheleva, D. I., Lane, D. P., Warbrick, E., & Blow, J. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5181 · Cited by 16
Regulation of the cell cycle by CDK inhibitors
Soos, T. J., Park, M., Kiyokawa, H., & Koff, A. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69686-5_5 · Cited by 16
Hwang, S. J., Cha, J. Y., Park, S. G., Joe, G. J., Kim, H. M., Moon, H. B., Jeong, S. J., Lee, J. S., Shin, D. H., Ko, S. R., et al. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9413 · Cited by 16
Mammalian DNA repair responses and genomic instability
Rhys, C. M. J. A., & Bohr, V. A. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9088-5_19 · Cited by 17
Induction of differentiation by wild-type p53 gene in a human glioma cell line
Kokunai, T., Kawamura, A., & Tamaki, N. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005732003296 · Cited by 17
“p21 forms multiple quarternary complexes with cyclins, cyclin-dependent kinases (CDKs), and proliferating cell nuclear antigen (PCNA) [13–15] and is transcriptionally induced by overexpression of wildtype p53 [10, 11] or by activation of p53 after DNA damage [16], consistent with a role for p21in the p53dependent G1 c…”
BackgroundRole of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and Fibrosis
Toh, B., Tu, Y., Cao, Z., Cooper, M. E., & Chai, Z. (2010) · Genes · doi:10.3390/genes1030335 · Cited by 15
“p21 expression induced by CDA1 is accompanied by inhibition of the activity of Cdk2 and Cdk1 activity, consistent with its binding to cyclins, Cdks, and the cyclin-Cdk complex [50–54].”
BackgroundMolecular mechanism of cell proliferation in rodent uterus during the estrous cycle
Baranda-Ávila, N., Mendoza-Rodríguez, C. A., Morimoto, S., Langley, E., & Cerbón, M. A. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.01.008 · Cited by 16
Marteil, G., Gagné, J., Borsuk, E., Richard‐Parpaillon, L., Poirier, G. G., & Kubiak, J. Z. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.09.003 · Cited by 16
p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma
Runnebaum, I. B., Köhler, T., Stickeler, E., Kieback, H., & Kreienberg, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.510 · Cited by 15
Singh, M., Singh, V., Baul, T. S. B., & Koch, B. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120937 · Cited by 14
Weis, K. E., & Raetzman, L. T. (2019) · Toxicology · doi:10.1016/j.tox.2019.152306 · Cited by 18
“In the pituitary gland the Cip and Kip family CDKIs, Cdkn1a (p21), Cdkn1b (p27) and Cdkn1c (p57), serve critical functions in normal cell differentiation and tumor suppression, and generally function as inhibitors to cell cyclin/CDKs (Bilodeau et al., 2009; Chen et al., 1995; García-Fernández et al., 2011; Philipp-Sta…”
BackgroundGong, Y., Deng, S., Zhang, M., Wang, G., Minuk, G. Y., & Burczynski, F. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600099 · Cited by 17
HER-2/Neu signaling and therapeutic approaches in breast cancer
Zhou, B. P., Li, Y., & Hung, M. (2002) · Breast Disease · doi:10.3233/bd-2002-15103 · Cited by 16
“The nuclear localization of p21 seems to be responsible for its cell-growth inhibition effect, and is controlled by the nuclear localization signal (NLS) at the C terminus of the molecule [13].”
Monahan, P., Himes, A. D., Parfieniuk, A., & Raetzman, L. T. (2011) · Mechanisms of Development · doi:10.1016/j.mod.2011.11.002 · Cited by 14
Li, H., Tian, Y., Li, X., Wang, B., Zhai, D., Bai, Y., Dong, C., & Xu, C. (2019) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15426261956343 · Cited by 13
Roles of the Skp2/p27 axis in the progression of chronic nephropathy
Suzuki, S., Ohashi, N., & Kitagawa, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1232-x · Cited by 16
“the involvement of PCNA in DNA replication [98, 99].”
Vuong, L., Brobst, D. E., Saadi, A., Ivanovic, I., & Al‐Ubaidi, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8681 · Cited by 14
“p21-mediated cell cycle arrest can also occur through downregulation of p21 by telomerase reverse transcriptase (TERT) in response to dysfunctional telomeres(45) and through inhibition of proliferating cell nuclear antigen (PCNA), an essential DNA polymerase d cofactor.(46,47) qRT-PCR analysis showed that transcript l…”
BackgroundFunctional Analysis of CDK Inhibitor p21WAF1
Fotedar, R., Bendjennat, M., & Fotedar, A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:055 · Cited by 16
Wu, B., Zhu, M., Ruan, T., Li, L. J., Lyu, Y., & Wang, H. S. (2018) · Research in Veterinary Science · doi:10.1016/j.rvsc.2018.10.009 · Cited by 12
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells
Dagg, R. A., Zonderland, G., Lombardi, E. P., Rossetti, G. G., Groelly, F. J., Barroso, S. I., Tacconi, E. M., Wright, B., Lockstone, H. E., Aguilera, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25215-0 · Cited by 14
Effect of methionine deficiency on the apoptosis and cell cycle of kidney in broilers
Song, B., Zeng, Q., Liu, Y., & Wu, B. (2019) · Research in Veterinary Science · doi:10.1016/j.rvsc.2019.09.013 · Cited by 12
Elliott, M. J., Stilwell, A., Dong, Y., Yang, H. L., Wong, S. L., Wrightson, W. R., Martin, R. C. G., & McMasters, K. M. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700458 · Cited by 15
Wu, D., Feng, C., Xu, X., Xiao, J., Liu, C., Meng, J., Wang, E., & Yu, B. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1743 · Cited by 14
Association of the Cell Cycle Regulatory Proteins p45SKP2 and CksHs1
Soler, L. M., Plaza, S., Vigorito, E., Serra‐Pages, C., & Vives, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102184200 · Cited by 12
Morris, M. C., & Divita, G. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2475 · Cited by 12
Ray, R., Saha, S., Pyne, N., Pal, A., & Paul, S. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.05.029 · Cited by 11
Yang, V. W. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00015-4 · Cited by 12
Akhter, N., Akhtar, S., Ahmad, M. M., Haque, S., Siddiqui, S., Hasan, S. I., Shukla, N. K., & Husain, S. A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3159-9 · Cited by 11
“The PCNA binding motif is located in the carboxy-terminal part of the p21 protein between residues 144–151 [35, 36] and alterations in this region results in structural changes in the protein product”
BackgroundZhang, S., Mu, Z., He, C., Zhou, M., Liu, D., Zhao, X., Goldman, D. J., & Xu, H. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18669 · Cited by 13
Huang, H., Chen, T., Zhou, Y., Geng, L., Shen, T. H., Zhou, L., & Zheng, S. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.28289 · Cited by 11
“We also examined the protein status of the G0/G1 phase such as p21, Rb [21-24].”
BackgroundCharacterization of Telomere-Binding Activity of Replication Factor C Large Subunit p140
Uchiumi, F., Watanabe, M., & Tanuma, S.-I. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0589 · Cited by 11
The Significance and Potential Molecular Mechanisms of Gastrointestinal Barrier Homeostasis
Andersson, R., & Wang, X. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709002984 · Cited by 11
Probing Protein-Protein Interactions with Mass Spectrometry
Kriwacki, R. W., & Siuzdak, G. E. (2003) · Humana Press eBooks · doi:10.1385/1-59259-045-4:223 · Cited by 11
Cannella, D., Roberts, J. M., & Fotedar, R. (1997) · Chromosoma · doi:10.1007/bf02529750 · Cited by 12
“Using systems for in vitro replication of DNA, cyclin-dependent kinases have been implicated as inducrs of DNA replication (McVey et al. 1989; Blow and Nurse 1990; D’Urso et al. 1990; Fang and Newport 1991; Fotedar and Roberts 1991; Dutta and Stillman 1992; Strausfeld et al. 1994; Chen et al. 1995; Chevalier et al. 19…”
BackgroundMethodInfluentialSikder, R. K., Ellithi, M., Uzzo, R. N., Weader, D. J., Metz, A. L., Behbahani, A., McKenzie, E. R., El‐Deiry, W. S., & Abbosh, P. H. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-1200 · Cited by 11
“p21 carries out its cellular functions primarily by binding its target proteins (35).”
Protein structure characterization with mass spectrometry
Kriwacki, R. W., Reisdorph, N. A., & Siuzdak, G. E. (2004) · Journal of Spectroscopy · doi:10.1155/2004/407960 · Cited by 10
“5) have been examined using protein mass mapping which exploits the high mass accuracy, resolution, and sensitivity of MALDI-MS [3,4,16–27].”
MethodTargetting Cdks in Cancer: An Overview and New Insights
Chashoo, G. (2014) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000313 · Cited by 11
“p21waf1 not only inhibits CDKs, but also proliferating cell nuclear antigen (PCNA) or E2F1 transcription factor [32,33].”
BackgroundDQ 65–79, A Peptide Derived from HLA Class II, Mimics p21 to Block T Cell Proliferation
Dong, C., Lyu, S., Krensky, A. M., & Clayberger, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5064 · Cited by 11
Post-transcriptional Destabilization of p21 by Protein Kinase C in Fibroblasts
Walker, J. L., Castagnino, P. A., Chung, B. M., Kazanietz, M. G., & Assoian, R. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609622200 · Cited by 10
The INK4a/ARF Locus and Human Cancer
Enders, G. H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:197 · Cited by 14
Nagai, J., Kigasawa, H., Koga, N., Katoh, A., Nishihira, H., & Nagao, T. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809058368 · Cited by 10
Targeting the Cardiomyocyte Cell Cycle for Heart Regeneration
Locatelli, P., Giménez, C. S., Vega, M. U., Crottogini, A., & Belaich, M. N. (2018) · Current Drug Targets · doi:10.2174/1389450119666180801122551 · Cited by 11
P21Waf1/Cip1 and p27Kip1 are correlated with the development and invasion of prolactinoma
Dong, W., Li, J., Liu, Q., Liu, C., Li, C., Song, G., Zhu, H., Gao, H., & Zhang, Y. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2683-6 · Cited by 9
The function of the human papillomavirus oncogenes
Pim, D., Thomas, M., & Banks, L. (2001) · Perspectives in medical virology · doi:10.1016/s0168-7069(01)05006-6 · Cited by 9
A role for molecular radiobiology in radiotherapy?
Gordon, A. T., & McMillan, T. J. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(05)80443-1 · Cited by 13
Kofod‐Olsen, E., Møller, J. M. L., Schleimann, M. H., Bundgaard, B. B., Bak, R. O., Øster, B., Mikkelsen, J. G., Hupp, T. R., & Höllsberg, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059223 · Cited by 10
Groth, A., & Willumsen, B. M. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.11.021 · Cited by 8
Weis, K. E., & Raetzman, L. T. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.09.027 · Cited by 10
A novel domain of BRCA1 interacts with p53 in breast cancer cells
Buck, M. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.061 · Cited by 8
“After DNA damage, increased synthesis and activity of p53 plays a critical role in p21 expression [19–21] and in the induction of cell cycle arrest and apoptosis [21,42,43].”
BackgroundFang, J., & Benbow, R. M. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.133.5.955 · Cited by 8
“It has also been reported that p21 inhibits DNA replication primarily through its inhibition of cdk2 in Xenopus egg extracts (Chen et al., 1995).”
p21CDKN1A and DNA Repair Systems: Recent Findings and Future Perspectives
Tillhon, M., Cazzalini, O., Dutto, I., Lucia, A., & Prosperi, E. (2013) · InTech eBooks · doi:10.5772/54173 · Cited by 7
“The main role of p21 is cell-cycle regulation, performed by inhibiting the activity of cyclinCDK complexes thanks to direct interaction through specific sequences (termed CDK and Cy motifs) in the N-terminal domain of the protein [10-13].”
BackgroundDutta, A. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69686-5_2 · Cited by 7
Self-citationSapheno-Femoral Junction Pathology: Molecular Mechanism of Saphenous Vein Incompetence
Urbanek, T., Skop, B., Ziaja, K., Wilczok, T., Wiaderkiewicz, R., Pałasz, A., Mazurek, U. M., & Wielgus-Serafińska, E. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000403 · Cited by 7
“The protein product of the p21(Waf/Cip1) encoding gene was identified as an inhibitor of cyclin-dependent kinases (cdks) (13,10,23,24).”
BackgroundAlteration of cell cycle progression by Sindbis virus infection
Yi, R., Saito, K., Isegawa, N., & Shirasawa, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.148 · Cited by 7
Dynamic Interaction between PARP-1, PCNA and p21waf1/cip1
Prosperi, E., & Scovassi, A. I. (2008) · Springer eBooks · doi:10.1007/0-387-36005-0_7 · Cited by 7
p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells
Draus, J. M., Elliott, M. J., Atienza, C. A., Stilwell, A., Wong, S. L., Dong, Y., Yang, H., & McMasters, K. M. (2001) · Experimental & Molecular Medicine · doi:10.1038/emm.2001.35 · Cited by 7
“, 1999), a growing body of evidence now points to an opposing relationship between E2F-1 and p21 in both cell cycle control and induction of apoptosis (Chen et al., 1995; Shiyanov et al., 1996; Dimri et al., 1996; Hiyama et al., 1998; Delavaine and La Thangue, 1999).”
BackgroundYokoyama, Y., Takahashi, Y., Morishita, S., Hashimoto, M., & Tamaya, T. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00193-6 · Cited by 7
Simonsen, S., Larsen, F. B., Søgaard, C. K., Jonsson, N., Lindorff‐Larsen, K., Bruheim, P., Otterlei, M., Hartmann‐Petersen, R., & Kragelund, B. B. (2025) · The FEBS Journal · doi:10.1111/febs.70133 · Cited by 7
“…functioning as a regulator of cell cycle progression [34] facilitated by the binding of p21 to cyclin-CDK complexes through its N-terminal domain [35 – 37]. p21 also plays a regulatory role in DNA replication and DNA damage repair and binds to PCNA via its C-terminal PIP-degron [38], blocking…”
Borel, V., Boeing, S., van Wietmarschen, N., Sridharan, S., Hill, B. R., Ombrato, L., Perez-Lloret, J., Jackson, D., Goldstone, R. J., Boulton, S. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110871 · Cited by 5
Jung, M.-S., Kim, W., Cho, J. W., Yang, W. H., & Chung, I. K. (2022) · Biochemical Journal · doi:10.1042/bcj20220391 · Cited by 9
PKCδ modulates p21WAF1/CIP1 ability to bind to Cdk2 during TNFα-induced apoptosis
Oh, Y.-T., Chun, K. H., Oh, J. I., Park, J. A., Kim, Y. U., & Lee, S. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.121 · Cited by 6
Identification of Pold2 as a novel interaction partner of protein inhibitor of activated STAT2
Zheng, Y., Sheng, S., Wang, H., Jia, X., Hu, Y., Qian, Y., Zhu, Y., & Wang, J. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1065 · Cited by 5
Hara, K., Tatsukawa, K., Nagata, K., Iida, N., Hishiki, A., Ohashi, E., & Hashimoto, H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105751 · Cited by 5
“The plasmids expressing GST-tagged p21 C-terminal region (GST-p21CT) was gifted from Dr Anindya Dutta (The University of Alabama at Birmingham) (48).”
MethodRegulation of Cell Cycle Progression
Scorah, J., & McGowan, C. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00302-8 · Cited by 6
Lu, Y., Yamagishi, N., Miyakoshi, J., Noda, A., Yagi, T., & Takebe, H. (1996) · Carcinogenesis · doi:10.1093/carcin/17.11.2343 · Cited by 5
Carnero, A. (2000) · Revista de Oncología · doi:10.1007/bf02978297 · Cited by 6
Infrequent p53 gene alterations in ulcerative colitis
Mattar, R., Alexandrino, A. M., & Laudanna, A. A. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000900005 · Cited by 5
“1 region (p53 locus) associated with mutation of the remaining allele in a variety of tumors (9), including sporadic colon cancer (6,10) and colon cancer associated with ulcerative colitis (11-14), indicated that wild type p53 was a tumor suppressor gene. p53 protein functions as a tumor suppressor, arresting the cell…”
BackgroundZhu, Y. Q., Lei, Y., Du, B., Zheng, Y., Lu, X., Tan, T., Kang, J., Sun, L., & Liang, Q. (2015) · PLoS ONE · doi:10.1371/journal.pone.0115704 · Cited by 4
“Cell-cycle arrest induces the function of p21 in promoting error-free replication-coupled DNA double-strandbreak (DSB) repair [6], as well as inhibiting DNA replication by binding with the proliferating cell nuclear antigen (PCNA), DNA polymerase-d and several other proteins involved in DNA synthesis [6–8].”
BackgroundFunctions of p21Waf1 in Norm and in Stress
Timofeev, O. V., Pospelova, T. V., & Поспелов, В. А. (2004) · Molecular Biology · doi:10.1023/b:mbil.0000032199.57820.43 · Cited by 4
“The three inhibitors show appreciable (39‐47%) homology of the N-terminal domain (about 60 residues), which contains a cyclin-binding (Cy) and a kinase-binding (K) site [2, 14 , 15].”
BackgroundXi, Y., Ding, K., Ren, Y., Shen, Y., & Ke, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205873 · Cited by 4
“The PCNA binding motif is located between codons 144 – 151, which overlaps in the highly conserved regions (Chen et al., 1995; Goubin and Ducommun, 1995).”
BackgroundMagalhães, H. I. F., & de Sousa, É. B. V. (2015) · Springer eBooks · doi:10.1007/978-3-319-19144-7_7 · Cited by 4
Bouchet, B. P., Fauvet, F., Grelier, G., Galmarini, C. M., & Puisieux, A. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.03.002 · Cited by 5
Morris, G., DeNardo, S. J., DeNardo, G. L., Leshchinsky, T. V., Wu, B., Mack, P. C., Winthrop, M. D., & Gumerlock, P. H. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2568 · Cited by 4
Diabetic LDL inhibits cell-cycle progression via STAT5B and p21waf
Brizzi, M. F., Dentelli, P., Pavan, M., Rosso, A., Gambino, R., Cesaris, M. G. D., Garbarino, G. M., Camussi, G., Pagano, G., & Pegoraro, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200213617 · Cited by 4
Purification and crystallization of cyclin‐dependent kinase inhibitor p21
Mayrose, D., Ke, H., Xiong, Y., & Nichols, M. A. (1996) · Protein Science · doi:10.1002/pro.5560050920 · Cited by 4
“Residues 1-71 alone are highly active in CDK binding and inhibition, and residues 141-160 efficiently bind PCNA and inhibit SV40 DNA replication in vitro (Chen et al., 1995; Luo et al., 1995; Nakanish et al., 1995).”
Li, Y., Wang, L., Li, S., Guo, T.-Q., Guo, X., Yan, P., Chen, Y., Wang, L., & Lu, C. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.001 · Cited by 4
The role of the cell cycle in genitourinary carcinoma
McGarvey, T. W., & Malkowicz, S. B. (1996) · World Journal of Urology · doi:10.1007/bf00184603 · Cited by 3
“Separate domains of the p21 (wAF1/CIPD protein interact with the cyclins and PCNA [12, 93].”
BackgroundCarosella, E. D., & Leteurtre, F. (1995) · Biofutur · doi:10.1016/s0294-3506(99)80211-7 · Cited by 3
Overview of the regulation of S-phase in Xenopus egg extracts
Chevalier, S., Chartrain, I., Philippe, M., & Ford, C. C. (1995) · Biochimie · doi:10.1016/0300-9084(96)88200-9 · Cited by 3
Hormonal Regulation of Neural Stem Cell Proliferation and Fate Determination
Brännvall, K. (2004) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 4
Safwat, S., Hathout, R. M., Ishak, R. A. H., & Mortada, N. D. (2024) · Scientia Pharmaceutica · doi:10.3390/scipharm92030050 · Cited by 2
Safwat, S., Hathout, R. M., Ishak, R. A. H., & Mortada, N. D. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107211 · Cited by 2
Designing Fluorescent Nuclear Permeable Peptidomimetics to Target Proliferating Cell Nuclear Antigen
Horsfall, A. J., Chav, T., Pederick, J. L., Kikhtyak, Z., Vandborg, B. C., Kowalczyk, W., Scanlon, D. B., Tilley, W. D., Hickey, T. E., Abell, A. D., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00471 · Cited by 2
Normal levels of p27Xic1are necessary for somite segmentation and determining pronephric organ size
Naylor, R. W., Collins, R. J., Philpott, A., & Jones, E. A. (2009) · Organogenesis · doi:10.4161/org.5.4.9973 · Cited by 2
“The C-terminal half possesses a PCNA-binding domain, also found in p21, and a QT-domain, a potential cdc2 phosphorylation site that occurs in p27.(22,23) Similar to full length p27, p27 N (amino acids 1–96) inhibits Cyclin/Cdk kinase activity and stops cell division before MBT.”
BackgroundBarbash, O., & Diehl, J. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10013-5 · Cited by 2
Kitaura, H., Shinshi, M., Uchikoshi, Y., Ono, T., Iguchi‐Ariga, S. M. M., & Ariga, H. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)80443-x · Cited by 2
Li, X. G., Gao, S., Yang, W. S., & Sun, S. (2021) · Folia Biologica · doi:10.14712/fb2021067010037 · Cited by 2
[The cell cycle and its role in the biology of haematopoietic progenitor cells].
Alvarado‐Moreno, J. A., & Mayani, H. (2007) · PubMed · Cited by 2
Mammalian Cell-Cycle Responses to DNA-Damaging Agents
Rowley, R. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-455-9_21 · Cited by 2
Lack of mutation in the gene during bovine leukemia virus-induced leukemogenesis
Dequiedt, F., Willems, L., Kerkhofs, P., Burny, A., & Kettmann, R. (1997) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(97)00081-0 · Cited by 1
Rb deficiency induces p21cip1 expression and delays retinal degeneration in rd1 mice
Lv, Z., Xiao, L., Tang, Y., Chen, Y., & Chen, D. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108701 · Cited by 3
Chapter 5 Molecular biology of prostate cancer
Gao, X., & Honn, K. V. (1999) · Advances in oncobiology/Advances in oncobiology (Print) · doi:10.1016/s1569-254x(99)80006-5 · Cited by 1
UV Response of Mammalian p53 Tumor Supressor Gene
Mälkönen, T. (1999) · Helda - University of Helsinki Institutional Repository · Cited by 1
Jordán, R. P. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-14852 · Cited by 1
Mitsunobu, O. N. O., Shindoh, M., Kobayashi, M., Higashino, F., Kohgo, T., Yoshida, K., & Totsuka, Y. (2004) · Oral Medicine & Pathology · doi:10.3353/omp.9.19 · Cited by 1
“2 (16) and its protein product forms a quaternary complex with cyclin, cyclin-dependent kinase (cdk) and the proliferating cell nuclear antigen (PCNA) (16, 18, 19). p21Waf1/Cip1 was shown to inhibit the kinase activity of cdks and to play a key role in cell-cycle arrest (20, 21).”
BackgroundA Transgenic Model to Study the Role of Oncogenes and Tumour Suppressor Genes in T-Cell Lymphoma
Blyth, K. (1996) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Vaccinia virus modulates the host cell cycle to promote infection
Martin, C. K. (2019) · UCL Discovery (University College London) · Cited by 1
Kato, J., Tomoda, K., Arata, Y., Tanaka, T., & Yoneda‐Kato, N. (2002) · Elsevier eBooks · doi:10.1016/b978-012476249-7/50007-2 · Cited by 3
Metadata
- Authors
- Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Venue
- Nature
- Published
- 1995-03
- Volume
- 374
- Issue
- 6520
- Pages
- 386-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2078690152
- Cited by
- 548
- References
- 16
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 20
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, WAF1/CIP1, p53, PCNA, proliferating cell nuclear antigen, protein domains, N-terminal domain, C-terminal domain, DNA replication inhibition, cell cycle arrest, growth inhibition, tumour suppressor
- MeSH terms
- Animals, Haplorhini, Binding Sites, Cell Division, Cell Line, Transformed, DNA Replication, Escherichia coli, Humans, Peptide Fragments, Recombinant Fusion Proteins, Simian virus 40, Tumor Cells, Cultured, Xenopus, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Xenopus Proteins, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.